DK0869958T3 - Hidtil ukendte indol-2,3-dion-3-oximderivater - Google Patents

Hidtil ukendte indol-2,3-dion-3-oximderivater

Info

Publication number
DK0869958T3
DK0869958T3 DK97941880T DK97941880T DK0869958T3 DK 0869958 T3 DK0869958 T3 DK 0869958T3 DK 97941880 T DK97941880 T DK 97941880T DK 97941880 T DK97941880 T DK 97941880T DK 0869958 T3 DK0869958 T3 DK 0869958T3
Authority
DK
Denmark
Prior art keywords
dione
het
oxime derivatives
ring
novel indole
Prior art date
Application number
DK97941880T
Other languages
Danish (da)
English (en)
Inventor
Frank Waetjen
Jorgen Drejer
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0869958T3 publication Critical patent/DK0869958T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK97941880T 1996-10-01 1997-10-01 Hidtil ukendte indol-2,3-dion-3-oximderivater DK0869958T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives
EP97941880A EP0869958B1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (1)

Publication Number Publication Date
DK0869958T3 true DK0869958T3 (da) 2005-04-18

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97941880T DK0869958T3 (da) 1996-10-01 1997-10-01 Hidtil ukendte indol-2,3-dion-3-oximderivater

Country Status (29)

Country Link
US (3) USRE38200E1 (sk)
EP (1) EP0869958B1 (sk)
JP (1) JP3319762B2 (sk)
KR (1) KR100492052B1 (sk)
CN (1) CN1093859C (sk)
AT (1) ATE286052T1 (sk)
AU (1) AU716435B2 (sk)
BG (1) BG63874B1 (sk)
BR (1) BR9706765A (sk)
CA (1) CA2238410C (sk)
CZ (1) CZ297938B6 (sk)
DE (1) DE69732090T2 (sk)
DK (1) DK0869958T3 (sk)
EE (1) EE9800144A (sk)
ES (1) ES2235253T3 (sk)
HK (1) HK1017682A1 (sk)
HU (1) HU225145B1 (sk)
IL (1) IL124563A (sk)
IS (1) IS2123B (sk)
NO (1) NO310722B1 (sk)
NZ (1) NZ330456A (sk)
PL (1) PL193041B1 (sk)
PT (1) PT869958E (sk)
RU (1) RU2190612C2 (sk)
SI (1) SI0869958T1 (sk)
SK (1) SK282729B6 (sk)
TR (1) TR199800956T1 (sk)
UA (1) UA54403C2 (sk)
WO (1) WO1998014447A1 (sk)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
DE69922936T2 (de) * 1998-03-31 2005-12-08 Neurosearch A/S Verwendung von indol-2,3-dione-3-oximderivate als ampa-antagonisten
WO2000071102A2 (en) * 1999-05-19 2000-11-30 Neurosearch A/S Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
ES2266214T3 (es) 2000-01-24 2007-03-01 Neurosearch A/S Derivados de isatina con actividad neurotrofica.
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
WO2002064139A1 (en) * 2001-02-15 2002-08-22 Neurosearch A/S Treatment of parkinson's disease by the combined action of a compound with neurotrophic activity and a compound enhancing the dopamine activity
MXPA04000358A (es) 2001-07-13 2004-05-04 Pharmacia & Up John Company Hexahidroazepino (4,5-g) indoles e indolinas como ligandos del receptor 5-ht.
WO2004018466A2 (en) * 2002-08-22 2004-03-04 Neurosearch A/S A method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
CA2630617C (en) 2005-11-23 2014-03-25 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2007115403A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20080004282A1 (en) * 2006-04-10 2008-01-03 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
ES2767707T3 (es) * 2015-04-29 2020-06-18 Janssen Pharmaceutica Nv Compuestos de indolona y su uso como moduladores de receptor AMPA
SG11201708190UA (en) 2015-04-29 2017-11-29 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
EP3288936B1 (en) 2015-04-29 2020-05-06 Janssen Pharmaceutica NV Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
BR112017023038A2 (pt) 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9204914A (es) * 1991-08-28 1993-07-01 Frank Watjen Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
DE69407407T2 (de) * 1993-05-13 1998-04-09 Neurosearch As Ampa antagonisten und behandlungsmethode
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
JP3164371B2 (ja) * 1994-09-14 2001-05-08 ノイロサーチ アクティーゼルスカブ インドール−２，３−ジオン−３−オキシム誘導体、その製造および使用
WO1996008495A1 (en) * 1994-09-14 1996-03-21 Neurosearch A/S Fused indole and quinoxaline derivatives, their preparation and use
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
DE69732090D1 (de) 2005-02-03
ES2235253T3 (es) 2005-07-01
SK67698A3 (en) 1998-11-04
TR199800956T1 (xx) 1998-12-21
WO1998014447A1 (en) 1998-04-09
PL193041B1 (pl) 2007-01-31
CN1093859C (zh) 2002-11-06
NO982466D0 (no) 1998-05-29
EP0869958A1 (en) 1998-10-14
RU2190612C2 (ru) 2002-10-10
NZ330456A (en) 1998-11-25
EP0869958B1 (en) 2004-12-29
UA54403C2 (uk) 2003-03-17
US6693111B1 (en) 2004-02-17
IL124563A (en) 2005-05-17
JP3319762B2 (ja) 2002-09-03
CA2238410C (en) 2007-06-12
HU225145B1 (en) 2006-07-28
IS2123B (is) 2006-07-14
CN1207100A (zh) 1999-02-03
BG63874B1 (bg) 2003-04-30
CA2238410A1 (en) 1998-04-09
IS4748A (is) 1998-05-18
NO982466L (no) 1998-07-31
USRE38200E1 (en) 2003-07-22
BR9706765A (pt) 1999-09-14
AU4376897A (en) 1998-04-24
ATE286052T1 (de) 2005-01-15
SI0869958T1 (en) 2005-06-30
KR100492052B1 (ko) 2005-09-30
MX9804365A (es) 1998-10-31
EE9800144A (et) 1998-10-15
CZ160698A3 (cs) 1998-10-14
PT869958E (pt) 2005-05-31
HUP9901630A2 (hu) 1999-08-30
CZ297938B6 (cs) 2007-05-02
KR19990071823A (ko) 1999-09-27
NO310722B1 (no) 2001-08-20
US6124285A (en) 2000-09-26
IL124563A0 (en) 1998-12-06
PL327073A1 (en) 1998-11-23
HUP9901630A3 (en) 2001-11-28
SK282729B6 (sk) 2002-11-06
JP2000501432A (ja) 2000-02-08
AU716435B2 (en) 2000-02-24
BG102489A (en) 1999-04-30
DE69732090T2 (de) 2005-12-29
HK1017682A1 (en) 1999-11-26

Similar Documents

Publication Publication Date Title
DK0869958T3 (da) Hidtil ukendte indol-2,3-dion-3-oximderivater
EA200100970A1 (ru) Аминопроизводные как ингибиторы протеазы
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
HUP0102563A2 (hu) Indolszármazékok és alkalmazásuk rosszindulatú és egyéb, patológiás sejtproliferáción alapuló megbetegedések kezelésére
HUP0204418A2 (hu) NHE-1 inhibitor hatású N-[(helyettesített öttagú, di- vagy triaza-, kétszeresen telítetlen gyűrű)-karbonil]-guanidin-származékok és alkalmazásuk
ATE157355T1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
NO174387C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive isoindolonderivater
ES2162466T3 (es) Derivados de 1,2,4-triazolo(4,3-b)pirido(3,2-d)piridazina y composiciones farmaceuticas que los contienen.
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
ATE161259T1 (de) Ampa antagonisten und behandlungsmethode
ATE197305T1 (de) Endothelin antagonisten
CO5140116A1 (es) Compuestos espiro derivados de imidazo-benzazepina con actividad antihistaminica y sus procesos de obtencion a partir de sus intermediarios de sintesis
ATE350397T1 (de) Par-2-aktivierendes peptidderivat und pharmazeutische zusammensetzung, in der dieses verwendet wird
HUP9903893A2 (hu) Eljárás szívelégtelenségnek ciklopentánnal kondenzált heterogyűrűs endotelin-antagonistákkal történő kezelésére
HUP0105406A2 (hu) Imidazo[1,2-a]kinolinszármazékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
AP2002002595A0 (en) Heterocyclic amide derivatives.
AR036554A1 (es) Coniosulfuros y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
ATE120749T1 (de) (3h,7h>thiazolo(3,4-a>pyridine mit antiasthmatischer und entzündungshemmender wirkung auf die atmungswege.
ES455436A1 (es) Procedimiento de preparacion de acidos tienotienilcarbonife-nilalcanoicos.